1. Home
  2. IMRN vs GTI Comparison

IMRN vs GTI Comparison

Compare IMRN & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • GTI
  • Stock Information
  • Founded
  • IMRN 1994
  • GTI 2019
  • Country
  • IMRN Australia
  • GTI Malaysia
  • Employees
  • IMRN N/A
  • GTI N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • GTI
  • Sector
  • IMRN Health Care
  • GTI
  • Exchange
  • IMRN Nasdaq
  • GTI NYSE
  • Market Cap
  • IMRN 9.2M
  • GTI 9.5M
  • IPO Year
  • IMRN N/A
  • GTI N/A
  • Fundamental
  • Price
  • IMRN $1.88
  • GTI $0.09
  • Analyst Decision
  • IMRN Strong Buy
  • GTI
  • Analyst Count
  • IMRN 1
  • GTI 0
  • Target Price
  • IMRN $5.00
  • GTI N/A
  • AVG Volume (30 Days)
  • IMRN 25.2K
  • GTI 30.6M
  • Earning Date
  • IMRN 07-07-2025
  • GTI 08-11-2025
  • Dividend Yield
  • IMRN N/A
  • GTI N/A
  • EPS Growth
  • IMRN N/A
  • GTI N/A
  • EPS
  • IMRN N/A
  • GTI N/A
  • Revenue
  • IMRN $4,048,286.00
  • GTI N/A
  • Revenue This Year
  • IMRN N/A
  • GTI N/A
  • Revenue Next Year
  • IMRN N/A
  • GTI N/A
  • P/E Ratio
  • IMRN N/A
  • GTI N/A
  • Revenue Growth
  • IMRN 82.90
  • GTI N/A
  • 52 Week Low
  • IMRN $1.50
  • GTI $0.06
  • 52 Week High
  • IMRN $2.87
  • GTI $5.69
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.70
  • GTI 47.48
  • Support Level
  • IMRN $1.68
  • GTI $0.07
  • Resistance Level
  • IMRN $1.94
  • GTI $0.09
  • Average True Range (ATR)
  • IMRN 0.09
  • GTI 0.01
  • MACD
  • IMRN 0.02
  • GTI 0.00
  • Stochastic Oscillator
  • IMRN 76.92
  • GTI 71.78

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: